1. Troein P, Newton M, Stoddart K, Arias A. The impact of biosimilar competition in Europe. 2022. Available from: https://www.iqvia.com/-/media/iqvia/pdfs/library/white-papers/the-impact-of-biosimilar-competition-in-europe-2022.pdf.
2. IQVIA. Assessing the biosimilar void. 2023. Available from: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/assessing-the-biosimilar-void.
3. Vulto AG, Vanderpuye-Orgle J, van der Graaff M, Simoens S, Dagna L, Macaulay R, et al. Sustainability of biosimilars in Europe: a delphi panel consensus with systematic literature review. Pharmaceuticals (Basel). 2020;13(11):400.
4. IQVIA. Advancing biosimilar sustainability in Europe. A multi-stakeholder assessment. 2018. Available from: https://www.biosimilars-nederland.nl/wp-content/uploads/2018/10/okt_2018_IQVIA_Pfizer_Advancing-Biosimilar-Sustainability-in-Europe.pdf.
5. GFK. Factors supporting a sustainable European biosimilar medicines market. 2014. Available from: https://www.medicinesforeurope.com/wp-content/uploads/2016/03/GfK_Final_Report-Factors_Supporting_a_Sustainable_European_Biosimilar_Medicines_Market.pdf.